GB001 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Asthma
Conditions
Asthma
Trial Timeline
Oct 22, 2018 → Aug 18, 2020
NCT ID
NCT03683576About GB001 + Placebo
GB001 + Placebo is a phase 2 stage product being developed by Gossamer Bio for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT03683576. Target conditions include Asthma.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03956862 | Phase 2 | Completed |
| NCT03683576 | Phase 2 | Completed |
Competing Products
20 competing products in Asthma